Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
定义高盐协同炎症细胞因子介导的乳腺癌进展后肿瘤微环境中的免疫足迹
基本信息
- 批准号:9211644
- 负责人:
- 金额:$ 7.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:4T1Academic Medical CentersAccountingAfricanAfrican AmericanAnti-Inflammatory AgentsAnti-inflammatoryAsian IndianBioinformaticsBiometryBreast Cancer ModelBreast Cancer cell lineCD3 AntigensCD4 Positive T LymphocytesCTLA4 geneCell Culture TechniquesCell ProliferationCellsChronicClinicalCollaborationsCouples TherapyDataDevelopmentDiagnostic Neoplasm StagingDietEffectivenessEffector CellEnvironmentEtiologyEventExposure toFosteringFunctional disorderGene Expression ProfileGenomicsGrantHispanicsHumanImaging TechniquesImmuneImmune responseImmunologic SurveillanceImmunologic TechniquesImmunosuppressionIn VitroInbred BALB C MiceInflammationInflammatoryInflammatory ResponseInterleukin-10Interleukin-17LaboratoriesLeadLearningLifeLinkMagnetic Resonance ImagingMalignant NeoplasmsMediatingMediator of activation proteinMolecularMouse Mammary Tumor VirusMusNeoplasm MetastasisOutcome StudyPathologyPatientsPhasePhenotypePlayProteinsRecruitment ActivityRegulatory T-LymphocyteResearchResistanceRoleSignal TransductionSiteSodiumSodium ChlorideSodium-Restricted DietStagingStudentsT-LymphocyteTennesseeTestingThe Vanderbilt-Ingram Cancer Center at the Vanderbilt UniversityTissuesTumor TissueTumor stageUniversitiesUp-RegulationVascular Endothelial Growth FactorsWomanWorkangiogenesisbasecancer cellcancer health disparitycancer initiationcancer preventioncell killingcommon treatmentcytokinedemographicsdietary restrictiondietary saltexhaustionexperiencefeedinghigh riskimaging modalityimmune activationimmune clearancein vivoinhibitor/antagonistinnovationmacrophagemalignant breast neoplasmmedical schoolsmonocytemouse modelnano-stringneoplastic cellnovelpreclinical studyresponsesalt intaketherapy developmenttriple-negative invasive breast carcinomatumortumor growthtumor microenvironmenttumor progression
项目摘要
Summary
Chronic inflammatory milieu and compromised T-cell immune-surveillance in the tumor microenvironment is
suggested to play a decisive role in cancer progression and metastasis. Although various immune effector
cells are recruited to the tumor site, their anti-tumor function is down-regulated in response to signals derived
from the tumor microenvironment. However, the precise molecular signals for this mechanism remain poorly
characterized. Our preliminary studies have demonstrated that stimulation of naive human CD4+T cells and
monocytes with high NaCl concentrations (0.2 M) resulted in a temporal-dependent bimodal effect on IL-17
secretion, with an initial increase (1-3 days), followed by a decrease in IL-17 secretion (5-7 days), and an
increase in anti- inflammatory IL-10 secretion. This later phase decrease in IL-17 after exposure to high salt
is accompanied by enhanced activation of immune-suppressive Tregs(CD4+Foxp3+) and MΦ2-like
macrophages, along with up-regulation of immune exhaustion markers (CTLA4, PD1, Tim3, LAG3) in CD4+T
cells. Thus, we hypothesize that high-salt concentration in the tumor microenvironment is linked to
modulation of IL-17, resulting in tumor growth with immune-exhaustion and immune-suppression responses.
These events lead to a dysfunctional late phase effector immune-elimination, culminating to enhance cancer
progression and metastasis. Using murine breast cancer models where mice are fed a diet with varying salt
content, we will utilize advanced sodium(Na23)-MRI and immunological techniques to test this hypothesis
with the following two specific aims: (1) Define and characterize the temporal effect on the functional changes
in infiltrating Treg (CD4+FoxP3+IL-10+T cells), Th17(CD4+IL-17+T cells), and macrophages (MΦ1/MΦ2
switch) leading to breast cancer progression; (2) Define the role of immune check-point inhibitors, CTLA4
and PD1 mAb, in high salt-mediated tumor progression compared to checkpoint inhibitor therapy combined
with a low-salt diet in two mouse models of breast cancer. We envision that the outcomes of this study will
help delineate the molecular mechanisms involved in high salt-mediated dysfunction of immune responses in
the tumor microenvironment with a potential clinical translational relevance of lowering salt tissue levels in
patients undergoing treatment with immune-check point inhibitors.
!
概括
肿瘤微环境中的慢性炎症环境和受损的 T 细胞免疫监视是
尽管多种免疫效应物在癌症进展和转移中起决定性作用。
细胞被招募到肿瘤部位,它们的抗肿瘤功能响应于衍生的信号而下调
然而,这种机制的精确分子信号仍然很差。
我们的初步研究表明,刺激初始人类 CD4+T 细胞和
高 NaCl 浓度 (0.2 M) 的单核细胞对 IL-17 产生时间依赖性双峰效应
分泌,最初增加(1-3 天),随后 IL-17 分泌减少(5-7 天),然后
暴露于高盐后,抗炎性 IL-10 分泌增加。后期 IL-17 减少。
伴随着免疫抑制 Tregs (CD4+Foxp3+) 和 MΦ2 样的增强激活
巨噬细胞,以及 CD4+T 中免疫耗竭标志物(CTLA4、PD1、Tim3、LAG3)的上调
因此,我们研究了肿瘤微环境中的高盐浓度与细胞的相关性。
IL-17 的调节,导致肿瘤生长并伴有免疫耗竭和免疫抑制反应。
这些事件导致晚期效应器免疫消除功能失调,最终加剧癌症
使用小鼠乳腺癌模型,给小鼠喂食不同盐的饮食。
内容中,我们将利用先进的钠(Na23)-MRI和免疫学技术来检验这一假设
具有以下两个具体目标:(1)定义和表征对功能变化的时间影响
浸润性 Treg(CD4+FoxP3+IL-10+T 细胞)、Th17(CD4+IL-17+T 细胞)和巨噬细胞(MΦ1/MΦ2
开关)导致乳腺癌进展;(2)定义免疫检查点抑制剂 CTLA4 的作用
和 PD1 mAb,与检查点抑制剂联合治疗相比,在高盐介导的肿瘤进展中
我们预计这项研究的结果将是在两种乳腺癌小鼠模型中进行低盐饮食。
帮助描述高盐介导的免疫反应功能障碍的分子机制
肿瘤微环境与降低盐组织水平具有潜在的临床转化相关性
接受免疫检查点抑制剂治疗的患者。
!
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anil Shanker其他文献
Anil Shanker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anil Shanker', 18)}}的其他基金
Diversity Center for Genome Research at Meharry
梅哈里基因组研究多样性中心
- 批准号:
10749781 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
Defining the effects of bortezomib on NK cell activation in cancer
确定硼替佐米对癌症 NK 细胞活化的影响
- 批准号:
8475316 - 财政年份:2013
- 资助金额:
$ 7.57万 - 项目类别:
Defining the effects of bortezomib on NK cell activation in cancer
确定硼替佐米对癌症 NK 细胞活化的影响
- 批准号:
9088384 - 财政年份:2013
- 资助金额:
$ 7.57万 - 项目类别:
Defining the effects of bortezomib on NK cell activation in cancer
确定硼替佐米对癌症 NK 细胞活化的影响
- 批准号:
8700356 - 财政年份:2013
- 资助金额:
$ 7.57万 - 项目类别:
Immunomodulatory effects of bortezomib on antitumor CD8 T-NK cell crosstalk
硼替佐米对抗肿瘤 CD8 T-NK 细胞串扰的免疫调节作用
- 批准号:
9770536 - 财政年份:2013
- 资助金额:
$ 7.57万 - 项目类别:
Pilot Project Developing immune checkpoint controlled -release biomaterials for cancer immunology
开发用于癌症免疫学的免疫检查点控释生物材料试点项目
- 批准号:
10493428 - 财政年份:2011
- 资助金额:
$ 7.57万 - 项目类别:
Pilot Project Developing immune checkpoint controlled -release biomaterials for cancer immunology
开发用于癌症免疫学的免疫检查点控释生物材料试点项目
- 批准号:
10327935 - 财政年份:2011
- 资助金额:
$ 7.57万 - 项目类别:
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
定义高盐协同炎症细胞因子介导的乳腺癌进展后肿瘤微环境中的免疫足迹
- 批准号:
10012769 - 财政年份:2011
- 资助金额:
$ 7.57万 - 项目类别:
Pilot Project Developing immune checkpoint controlled -release biomaterials for cancer immunology
开发用于癌症免疫学的免疫检查点控释生物材料试点项目
- 批准号:
10705096 - 财政年份:2011
- 资助金额:
$ 7.57万 - 项目类别:
Defining immune footprint in tumor microenvironment following high salt synergized inflammatory cytokine mediated breast cancer progression
定义高盐协同炎症细胞因子介导的乳腺癌进展后肿瘤微环境中的免疫足迹
- 批准号:
9765058 - 财政年份:
- 资助金额:
$ 7.57万 - 项目类别:
相似海外基金
Elucidating Non-Routine Events Arising from Interhospital Transfers
阐明院间转移引起的非常规事件
- 批准号:
10749448 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
Deconvolution of Physicochemical Properties Contributing to Passive Diffusion of Depsipeptides
有助于缩酚肽被动扩散的物理化学性质的反卷积
- 批准号:
10607589 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
Neurophysiologic Correlates of Sensory Over-Responsivity in Tourette Syndrome
抽动秽语综合征感觉过度反应的神经生理学相关性
- 批准号:
10644333 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别:
Development of ALM-488 for nerve and ureter visualization during abdominal surgery
开发用于腹部手术期间神经和输尿管可视化的 ALM-488
- 批准号:
10699258 - 财政年份:2023
- 资助金额:
$ 7.57万 - 项目类别: